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Abstract: The entry of ricin toxin into macrophages and certain other cell types in the 
spleen and liver results in toxin-induced inflammation, tissue damage and organ failure. It 
has been proposed that  uptake of ricin into macrophages is facilitated by the mannose 
receptor (MR; CD206), a C-type lectin known to recognize the oligosaccharide side chains 
on ricin’s A (RTA) and B (RTB) subunits. In this study, we confirmed that the MR does 
indeed promote ricin binding, uptake and killing of monocytes in vitro. To assess the role 
of MR in the pathogenesis of ricin in vivo, MR knockout (MR
−/−) mice were challenged 
with the equivalent of 2.5×  or 5×  LD50 of ricin by intraperitoneal injection. We found that 
MR
−/−  mice  were  significantly  more  susceptible  to  toxin-induced  death  than  their  
age-matched, wild-type control counterparts. These data are consistent with a role for the 
MR in scavenging and degradation of ricin, not facilitating its uptake and toxicity in vivo.  
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1. Introduction 
Ricin toxin, a natural product of the castor bean plant (Ricinus communis), is one of the most potent 
toxins known. Ricin is capable of killing virtually all mammalian cell types, and can be lethal to 
humans following injection, inhalation or ingestion. The study of ricin has led to the discovery of 
fundamental  processes  in  areas  of  protein  science,  cell  biology  and  immunology,  and  has  had 
important applications for immunotherapeutics [1–3]. At the same time, ricin has sordid history as a 
biological weapon. During World War II, ricin was weaponized under the code name “Compound W” 
by  the  US  military,  although  the  toxin  was  never  used  in  combat  [4,5].  The  KGB  employed  a  
ricin-laced metal pellet in the London assassination of the Bulgarian dissident Georgi Markov in 1978, 
and the toxin remains one of the more common “white powders” encountered by law enforcement [6,7]. 
For these reasons, the Centers for Disease Control have classified ricin as a Category B Select Agent, 
and  the National  Institutes  of Health and (NIAID)  considers the development of countermeasures 
against ricin a research priority [8]. 
Ricin is a member of the so-called A-B family of toxins. The toxin consists of a 267 amino acid A 
subunit (RTA) and 262 amino acid B subunit (RTB) that are joined via a single disulfide bond. RTA is 
a ribosome inactivating protein (RIP) whose exclusive substrate is a universally conserved adenosine 
moiety within the so-called sarin/ricin loop (SRL) of eukaryotic ribosomal RNA [9]. RTA is so potent 
that a single molecule is sufficient to kill a cell [10]. Ricin’s B subunit (RTB) is a lectin specific for  
β-1,3-linked  galactose  and  N-acetylgalactosamine  (Gal/GalNac)  residues  on  both  glycolipids  and 
glycoproteins [11]. Both RTA and RTB are post-translationally modified via N-linked mannose side 
chains. RTA has at least one modification at position Asn10 (GlcNAc2Man4), while RTB has two 
modifications at positions Asn95 (GlcNAc2Man6) and Asn135 (GlcNAc2Man7) [12,13]. 
The pathogenesis of ricin toxin has been studied in small animal models, especially rodents [14]. 
Following intravenous administration, ricin is cleared from the circulation and accumulates primarily 
within the liver and spleen, although residual amounts of the toxin are also found in the lungs, kidneys 
and intestines [15–20]. Within the spleen and liver, macrophages (Mʦ) cells are the first (and most 
severely)  affected  by  the  toxin.  As  early  as  four  hours  post  challenge,  Kupffer  cells  exhibit 
ultrastructural  changes  consistent  with  the  initiation  of  apoptosis  [15].  In  parallel,  toxin-mediated 
tissue  damage  is  accompanied  by  a  severe  inflammatory  response,  which  has  been  postulated  to 
originate from Mʦs [16,21]. Consistent with this model is the fact that Mʦs exposed to ricin in vitro 
results in the activation of stress-activated protein kinases and secretion of an array of pro-inflammatory 
cytokines and chemokines [22–25]. 
Macrophages are proposed to internalize ricin by two distinct pathways [26,27]. The first pathway 
involves  RTB-mediated  attachment  to  galactosyl  residues  on  surface  localized  glycoproteins  and 
glycolipids. Once bound to the cell surface via RTB, ricin is endocytosed and trafficked retrograde to 
the endoplasmic reticulum (ER), where RTA dissociates from RTB and is retro-translocated across the 
ER membrane into the cytosol [3,28]. This pathway is relatively inefficient in that only a fraction 
(<5%) of the total amount of RTA internalized by this route gains access to the TGN; the vast majority 
of ricin is recycled to the cell surface or degraded [29]. On the other hand, the pathway is largely 
insaturable, as it is estimated that there are more than 1 ×  10
6–7 RTB bindings sites on the surface of a 
typical  cell  [30].  The  second,  and  biochemically  distinct,  uptake  pathway  involves  the  mannose Toxins 2011, 3                                       
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receptor (MR) [26,27,31]. The MR, also known as CD206, is a 180 kDa transmembrane C-type lectin 
that binds oligosaccharides terminating in mannose, fucose or N-acetylglucosamine [32,33]. Simmons 
and colleagues first demonstrated that ricin uptake into rat peritoneal macrophages was reduced by 
either addition  of exogenous  lactose or mannan, and that maximal  inhibition  occurred when both 
lactose and mannan were present [27]. At the time, the only described mannose binding protein on 
peritoneal macrophages was the MR; a number of other mannose-specific lectins have since been 
identified [34]. 
Despite the potential importance of the MR in ricin pathogenesis, the contribution of the MR to 
ricin intoxication in vivo has never been directly examined. Studies aimed at addressing this issue have 
relied  on  indirect  means  of  blocking  MR  activity,  such  as  co-injection  of  high  concentrations  of 
mannan with ricin in an attempt to saturate endogenous MR activity [31]. While these studies strongly 
support  a  role  for  the  MR  in  ricin  uptake  in  vivo,  they  are  confounded  by  the  possibility  that 
insufficient mannan was present to fully saturate the MR, or that other C-type lectins (e.g., DC-SIGN) 
in addition to the MR may be involved in ricin recognition and uptake. Defining the exact role of  
the  MR  in  ricin  pathogenesis  would  be  most  easily  addressed  through  the  use  knockout  mice 
specifically  deficient  in  the  MR.  In  fact,  the  laboratory  of  Dr.  Michel  Nussenzweig  recently  
produced and characterized MR knock out (MR
−/−) mice [35]. The MR
−/− mice were demonstrably 
impaired in their ability to clear serum glycoproteins, a phenotype that is consistent a role for the MR 
in promoting the recognition, degradation and excretion of endogenously- and exogenously-derived 
mannosylated-ligands. 
Thus, the overarching goal of this study was to take advantage of the availability of MR
−/− mice to 
directly  determine  the  role  of  the  MR  in  mediating  the  pathogenesis  of  ricin  in  vivo.  If  the  MR 
functions in facilitating ricin uptake into Mʦs or other cell types, then we would expect that MR
−/− 
mice will be more resistant to ricin challenge than their wild type counterparts. On the other hand, if 
the MR promotes the clearance and/or degradation of ricin from circulation, as it does for other serum 
glycoproteins, then MR
−/− mice would be expected to be more sensitive to ricin challenge. In this 
study, we first confirm that the MR does indeed promote the binding and uptake of ricin into Mʦs  
in vitro. We then perform ricin challenge studies with wild type and MR
−/− mice and demonstrate that 
the MR
−/− mice are in fact more sensitive to ricin than wild type control animals. These and other 
results  strongly  suggest  that  the  MR  is  ultimately  involved  in  innate  immunity  to  ricin,  probably 
through the capacity of the receptor to accelerate ricin clearance and degradation.  
2. Materials and Methods 
2.1. Chemicals, Reagents and Antibodies 
Ricin  and  ricin  conjugated  to  fluorescein  isothiocyanate  (FITC)  were  purchased  from  Vector 
Laboratories  (Burlingame,  CA).  Ricin  was  dialyzed  against  PBS  at  4  ° C  in  10,000  MW  cutoff  
Slide-A-Lyzer dialysis cassettes (Pierce, Rockford, IL), prior to use in cytotoxicity and animal studies. 
Fluorophore- and biotin-conjugated monoclonal antibodies (mAbs) directed against the human (clone 
15–2) and mouse (clone MR5D3) mannose receptors were purchased from BioLegend (San Diego, Toxins 2011, 3                                       
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CA).  Yeast  mannan  was  obtained  from  Sigma-Aldrich  (St.  Louis,  MO).  Cell  culture  media  were 
prepared by the Wadsworth Center Media Services facility.  
2.2. Cytotoxicity and Apoptosis Assays 
THP-1 cells are a monocytic leukemic cell line [36] that we obtained from the American Type 
Culture Collection (ATCC, Manassas, VA). The cells were passaged in complete RPMI containing 
10%  fetal  bovine  serum  and  were  maintained  in  a  humidified  incubator  (37  ° C,  5%  CO2).  For 
cytotoxicity assays, the cells were adjusted to 5 ×  10
4 cells per mL, seeded (100 L/well) onto white 
96 well plates (Corning Life Sciences, Lowell, MA). Twenty-four hours later, the cells were treated 
with ricin (50 ng/mL) for 2 h at 37 ° C. The cells were then washed to remove unbound toxin and 
incubated for an additional 40 h. Cell viability was assessed using CellTiter-GLO reagent (Promega, 
Madison, WI) according to the manufacturer’s instructions, except the reagent was diluted 1:5 in PBS 
before use. Luminescence was measured with a SpectraMax L luminometer interfaced with SoftMax 
Pro software (version 5.2;  Molecular Devices,  Sunnyvale, CA). All  treatments  were performed in 
triplicate  and  100%  viability  was  defined  as  the  average  value  obtained  from  wells  treated  with 
medium only.  
Annexin-V staining was used as a surrogate marker of cells undergoing apoptosis [37]. THP-1 cells 
(1 ×  10
6 cells per mL) were seeded into 12 well cell culture plates (Corning). The cells were then 
incubated at 37 ° C with ricin (1 μg/mL), ricin-mAb mixtures or ricin-polysaccharide mixtures for  
4.5  hours.  After  incubation,  the  cells  were  collected  by  centrifugation  and  then  re-suspended  in  
1X binding buffer (100 μL) containing 5 L of Annexin V-FITC and 5 μL PI, as recommended by the 
manufacturer  (BD  Biosciences).  Samples  were  assayed  for  apoptosis  and  necrosis  using  a  FACS 
Calibur  (BD  Biosciences).  Results  were  reported  as  %  cells  positive  for  Annexin  V-FITC  or  PI.  
A minimum of 20,000 cells were analyzed per sample. 
2.3. Toxin Binding Assays 
To  examine  ricin  binding  to  cell  surfaces,  THP-1  monocyte  cells  were  washed  and  then 
resuspended in 4 ° C HBSS at a concentration of 1 ×  10
6 mL. The cells were then chilled on ice for  
20 min and then incubated with FITC-labeled ricin (1 μg/mL) in the presence of specific mAbs or 
sugars for 20 min. The cells were then washed with HBSS to remove unbound ricin-FITC, fixed in 1% 
paraformaldehyde for 10 min, and resuspended in PBS with 2% goat serum (Invitrogen) containing  
1 mM NaN3. The cells were subjected to flow cytometry using a FACSCalibur (BD Biosciences).  
A minimum of 20,000 cells were analyzed per sample.  
2.4. Animals and Ricin Challenge Studies 
MR
−/−  breeder  pairs  were  kindly  provided  by  the  laboratory  of  Dr.  Michel  Nussenzweig 
(Rockefeller  University,  New  York,  NY)  [35].  Animals  were  housed  under  conventional,  specific 
pathogen-free conditions and were treated in compliance with the Wadsworth Center’s Institutional 
Animal Care and Use Committee (IACUC) guidelines. For challenge studies, ricin was diluted into 
DPBS and administered by intraperitoneal injection to groups of MR
−/− mice (8–12 weeks of age) and Toxins 2011, 3                                       
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gender-  and  age-matched  C57/B6  control  mice.  Survival  was  monitored  over  a  3-day  period. 
Hypoglycemia was used as a surrogate marker of intoxication. Blood glucose levels were measured 
using an Aviva ACCU-CHECK handheld blood glucose meter (Roche, Indianapolis, IN). Mice were 
euthanized when their blood glucose levels fell below 25 mg/dL. For statistical purposes, readings at or 
below the meter’s limit of detection of ~12 mg/dL were set to that value.  
To estimate the half-life of ricin in serum, groups of age- and gender-matched wild type and MR
−/− 
mice injected intravenously with biotinylated ricin (100  μg/mouse). Blood was collected from the 
animals 30 min and 60 min later by intra-orbital bleed. Ricin levels in serum were determined by 
ELISA in which NUNC Maxisorb F96 microtiter plates (Thermo Fisher Scientific, Waltham, MA) 
were coated overnight with the RTB-specific mAb 24B11 (1 μg/mL) [38] to capture ricin, treated with 
sera from biotin-ricin challenged mice, and then horseradish peroxidase (HRP)-labeled avidin (Sigma 
Aldrich Co., St. Louis, MO). The plates were developed using the colorimetric detection substrate 
3,3′,5,5′-tetramethylbenzidine (TMB; Kirkegaard & Perry Labs, Gaithersburg, MD) and were analyzed 
with a SpectroMax 250 spectrophotometer.  
To further investigate leukocyte apoptosis in the spleens of ricin challenged mice, groups of MR
−/− 
mice and gender- and age-matched C57/B6 control mice were challenged with ricin (1 μg) by IP 
injection.  Eighteen  hours  later,  the  animals  were  euthanized  and  spleenocytes  were  physically 
dissociated  in  DMEM  +10%  FBS.  After  centrifugation  (400  ×   g)  for  5  min,  the  cells  were  then 
incubated in 0.17 M ammonium chloride (pH 7.4) for 10 min to lyse red blood cells. After incubation, 
the cells were collected by centrifugation and then suspended in 1×  binding buffer (100 μL) containing 
5  μL  of  Annexin  V-FITC  and  5  μL  PI,  as  recommended  by  the  manufacturer  (BD  Biosciences). 
Samples were assayed for apoptosis and necrosis using a FACS Calibur (BD Biosciences).  
Levels  of  the  pro-inflammatory  cytokine  and  chemokines  γ-interferon,  interleukin  (IL)-1,  IL-6,  
IL-12p70, monocyte chemotactic protein 1 (MCP-1), and tumor necrosis factor (TNF)-ʱ  levels  in 
splenic homogenates were determined using a BD CBA Mouse Inflammation kit (BD Biosciences). 
The cytokine/chemokine concentrations were calculated from standard curves generated from purified 
cytokines/chemokines provided by the manufacturer.  
2.5. Statistical Analysis and Software 
Statistical analysis was carried out with GraphPad Prism 5 (GraphPad Software, San Diego, CA). 
For  survival  studies,  statistical  significance  between  groups  was  determined  using  the  Log-Rank 
(Mantel-Cox)  test.  Differences  in  blood  glucose  levels  and  cytokine  levels  were  determined  by  
two-way analysis of variance (ANOVA). 
3. Results 
3.1. MR Contributes to Ricin-Induced Killing of Monocytes in Vitro 
THP-1  cells  are  a  human  acute  monocytic  leukemia  cell  line  used  widely  as  a  model  for  
monocyte-derived macrophages [36]. These cells are known to express a number of C-type lectins, 
including the MR [39–41], even in their undifferentiated state. Furthermore, these cells are highly 
sensitive to the effects of ricin (Figure 1).  Toxins 2011, 3                                       
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Figure 1. Sensitivity of THP-1 cells to ricin toxin. THP-1 cells (5 ×  10
4 cells per mL) were 
treated with indicated concentrations of ricin for 2 h at 37 ° C. The cells were then washed 
to remove unbound toxin and incubated for an additional 40 h. Cell viability was assessed 
using as described in Materials and Methods. 
 
We therefore used these cells as a model system to verify previous reports demonstrating a role for 
the MR in ricin uptake and toxicity [27]. To assess the role of the MR in promoting ricin attachment to 
cells, THP-1 cells were exposed to FITC-ricin (1 μg/mL) at 4 °C  for 20 min, washed, fixed, and then 
subjected to flow cytometry. These studies were conducted at 4 °C  to permit binding to cells, but not 
endocytosis  [42].  FITC-ricin  bound  cells  with  a  MFI  of  ~80  (Figure  2A).  Toxin  binding  to  cell 
surfaces was reduced by  ~25% upon the addition of mannan (10 mg/mL) and more than 50% by 
treatment of the cells with a MR-specific blocking mAb. Activation of the THP-1 cells with IL-4 
resulted in increased surface expression of the MR and a concomitant increase in ricin binding that was 
also partially inhibited by mannan and the MR-specific blocking mAb (data not shown). These results 
confirm a role for the MR in toxin attachment to cell surfaces. 
To define the role of the MR in ricin toxicity, cells were exposed to ricin (1 μg/mL) for 5 h and then 
assessed for apoptosis by staining the cells with annexin-V. Following ricin treatment, approximately 
60% of the  cells  stained positive for annexin  V, indicating that  apoptosis had been initiated  in  a 
majority of the cells population (Figure 2B). The addition of anti-MR mAb (20 μg/mL) or excess 
mannan (10 mg/mL) partially protected the cells from the effects of ricin, consistent with a role for the 
MR in ricin uptake. The degree of protection conferred by the anti-MR mAb and mannan was only 
slightly less than that conferred by the well-characterized neutralizing mAb R70 [38,43]. Interestingly, 
the addition of galactose virtually eliminated ricin-induced cell killing, underscoring the contribution 
of  RTB-mediated  uptake  via  terminal  galactose  residues  in  ricin  entry  into  host  cells.  
The combination of galactose and mannan was not more effective than galactose alone in preventing 
toxin-induced killing, which has implications for the role of MR in ricin uptake (see below).  
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Figure  2.  Contribution of the Mannose Receptor (MR) in ricin binding and uptake by 
THP-1 cells. (A) Role of MR in ricin attachment. THP-1 cells (1 ×  10
6 cells/mL) were 
chilled  on  ice  for  20  minutes  to  arrest  endocytosis.  Cells  were  then  treated  with  
FITC-labeled ricin (1 μg/mL) in the presence of mannan (10 mg/mL) or the blocking anti-
MR mAb 15–1 for 20 min before being subjected to flow cytometric analysis. Geo Mean 
refers to the geometric mean fluorescence emission at 519 nm when cells were exposed to 
an excitation signal 488 nm; and (B) Role of the MR in ricin cytotoxicity. THP-1 cells (1 ×  
10
6 cells per mL) were incubated with ricin (1 μg/mL), ricin-mAb mixtures, or ricin-sugar 
(mannan or galactose) mixtures 4.5 h. After which the cells were assayed for Annexin-V 
expression  (gray  bars)  as  an  indicator  of  apoptosis  and  PI  staining  (black  bars)  as  an 
indicator of necrosis. The Y-axis refers to % cells that were positive for Annexin V-FITC 
or PI. A minimum of 20,000 cells were analyzed per sample. 
 
3.2. Sensitivity of MR
−/− Mice to Ricin Intoxiction 
Having confirmed a role for the MR in the binding to and uptake by a monocyte cell line in vitro, 
we next wished to examine the contribution of the MR to in vivo. We obtained MR
−/− breeder pairs 
from the laboratory of Dr. Michel Nussenzweig at the Rockefeller University [35]. Groups of age-, 
weight and sex-matched C57BL/6 and MR
−/− mice were challenged with 1.0 μg or 0.5 μg of ricin, 
which in wild type mice is the equivalent of 5×  LD50 or 2.5×  LD50, respectively. Mice were then 
monitored  for  morbidity  and  mortality  for  three  days.  Hypoglycemia  was  used  as  a  quantitative 
surrogate marker of ricin intoxication [44]. 
Wild-type mice challenged with 1 μg of ricin (equivalent to 5×  LD50) succumbed to intoxication 
within 48 h, with a median survival of 34 h (Figure 3A). In contrast, all the MR
−/− mice challenged 
with the same amount of toxin expired within 24 h, with a median survival of 19 h (Figure 3A). The 
enhanced susceptibility of the MR
−/− mice to ricin intoxication was also apparent in the groups of mice 
challenged with 0.5 μg: wild-type mice had a median survival of 66 h, whereas the MR
−/− mice had a 
median survival of only 36 h (Figure 3B). The kinetics of hypoglycemia mirrored the time to death 
curves for both groups of animals. (Figures 3C,D) In both the high and low ricin challenge groups, the 
MR
−/− mice demonstrated a more rapid reduction in blood glucose levels as compared to their wild 
type counterparts. These data reveal that the MR
−/− mice are approximately two-times more sensitive 
to ricin than wild type mice.  Toxins 2011, 3                                       
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Figure 3. Survival of MR
−/− mice following ricin challenge. Groups of MR
−/− or age- and 
sex-matched  wild  type  controls  were  challenged  with  1.0  μg  (panels  A,  B)  or  0.5  μg 
(panels  C,  D)  ricin.  Groups  of  animals  were  monitored  for  survival  (A,  C)  and 
hypoglycemia (B, D). Panels A, C: At both challenge doses, the MR
−/− mice succumbed to 
ricin intoxication at a rate significantly greater than their wild type counterparts (p < 0.01 
by the Log-Rank test). Panels B and D: each symbol represents an individual mouse. For 
mice challenged with 1.0 μg ricin (panel A), blood glucose levels in the MR
−/− mice were 
significantly  lower  that  their  wild  type  counterparts  at  19  h  (p  <  0.001)  and  24  h  
(p < 0.001) post challenge, as determined by two-way ANOVA. For mice challenged with 
0.5 g ricin (panel B), blood glucose levels in the MR
−/− mice tended to be lower than wild 
type controls, although this difference was not statistically significant.  
 
To examine whether the serum half-life of ricin was affected by the absence of the MR, groups of 
wild  type  or  knock-out  mice  were  administered  ricin  intravenously.  Toxin  levels  in  serum  were 
determined by ELISA 30 and 60 min later. By this method, there was no detectable difference in the 
clearance  of  ricin  from  circulation  between  the  wild-type  and  MR
−/−  mice  (data  not  shown). 
Furthermore,  the  levels  of  ricin-induced  apoptosis  in  the  spleens  wild-type  and  MR
−/−  mice  were 
identical (Figure 4), indicating that equal amounts of toxin likely gained access to this (and other) 
visceral organs.  Toxins 2011, 3                                       
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Figure  4.  Toxin-induced  apoptosis  in  the  spleens  of  MR
−/−  and  wild  type  mice. 
Splenocytes  from  wild  type  and  MR
−/−  control  and  ricin-challenged  mice  (18  h  post 
challenge) were subjected to Annexin V-FITC (gray bars) and PI staining (black bars) as 
indicators of apoptosis and necrosis, respectively. There was no significant difference in 
apoptosis numbers between the wild type and mannose receptor-deficient animals.  
 
Interestingly, however, IL-6 levels in the spleens of ricin-challenged MR
−/− mice were 2–6 fold 
higher  than  was  observed  in  the  ricin-challenged  wild  type  controls  (Figure  5).  Other  cytokines, 
notably MCP-1, TNF-ʱ, IL-1 and IFN-γ were altered but not significantly different between the groups 
of animals (Figure 5C, data not shown). These data demonstrate that the absence of the MR does not 
affect toxin-induced cell death in the spleen, but does influence pro-inflammatory cytokine/chemokne 
responses in the serum.  
Figure 5. Cytokine and chemokine levels in splenic homogenates of MR
−/− and wild type 
mice following ricin challenge. Splenic homogenates from groups of wild type and MR
−/− 
control  and  ricin-challenged  mice  (18  h  post  challenge)  were  subjected  mouse 
inflammatory cytokine/chemokine cytometric bead array. Shown are values from IL-6 (A), 
MCP-1 (B), and TNF-ʱ (C). The differences in IL-6 levels in ricin-challenged MR
−/− mice 
were  significantly  greater  than  those  in  ricin-challenged  control  animals  (p  <  0.05,  as 
determined by ANOVA). 
 
Finally, we also examined pro-inflammatory cytokine/chemokine responses in the intestinal mucosa 
in MR
−/− mice following an intragastric ricin challenge. We previously reported that MCP-1 (but not 
TNF-ʱ, IL-1, IL-6 or IFN-γ) is a hallmark of ricin-induced damage to the intestinal mucosa [45]. 
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Groups  of  wild-type  and  MR
−/−  mice  were  challenged  intragastrically  with  5  mg/kg  of  ricin. 
Approximately 24 h later, the animals were euthanized and intestinal homogenates were assayed by 
CBA analysis for cytokine/chemokine levels. MCP-1 levels were elevated in ricin-challenged mice, as 
compared  to  sham  challenged  controls  (data  not  shown).  There  was  no  difference,  however,  in  
MCP-1 levels at baseline or following toxin challenge between wildtype and MR
−/− mice. 
4. Conclusions and Discussion 
In  this  study,  we  took  advantage  of  the  availability  of  MR
−/−  mice  to  examine  the  role  of  
MR-mediated  uptake  in  the  pathogenesis  of  ricin  toxin  in  vivo.  We  found  that  MR
−/−  mice  were 
approximately two-fold more sensitive to ricin-induced killing than their wild-type counterparts. MR
−/− 
mice challenged with the equivalent of 2.5×  or 5×  LD50 of ricin demonstrated a more rapid reduction 
in blood glucose levels and an accelerated time to death, as compared to control animals. While these 
data  are  surprising  in  light  of  the  fact  that  the  MR  actually  promotes  ricin-induced  apoptosis  of 
monocytes/macrophages  in  vitro,  they  are  entirely  consistent  with  the  MR’s  established  role  as  a 
scavenging receptor and an important component of the innate immune system [32,33,35]. Thus, we 
propose that MR-mediated uptake of ricin by macrophages (and other cell types) in vivo results in the 
clearance and degradation of the toxin, and does not lead to an increase in toxin-induced cell death or 
an  increased inflammatory  response.  In the  absence of the MR, ricin  internalization likely occurs 
entirely through the RTB-mediated uptake pathway. 
As a member of the C-type lectin family of pattern recognition receptors (PRRs), the MR has been 
shown to bind (and in some cases mediate phagocytosis of) a variety of bacterial and fungal pathogens, 
including Mycobacterium tuberculosis [46], Streptococcus pneumoniae [47], Francisella tularensis [48], 
Pneumocystis carinii [49], Candida albicans [50], and Cryptococcus neoformans [51]. It has been 
postulated that microbial pathogens exploit the MR as a means to gain entry into host cells. With the 
exception of F. tularensis [48], however, this postulate has not been substantiated. For example, mice 
lacking the MR are more sensitive (not more resistant) to Cryptococcus neoformans infection than 
wild type animals, as reflected by faster time to death and higher fungal burdens following pulmonary 
challenge [51]. Thus, it is generally accepted that the primary function of the MR is in antigen capture 
and degradation. Indeed, the MR may be integral in linking the innate and adaptive immune responses, 
as evidenced by the fact that MR-mediated uptake of certain exogenous glycoproteins by dendritic 
cells results in cross-presentation to CD8
+ T cells [52]. While our data clearly support a role for the 
MR  in  the  clearance  of  ricin  from  circulation,  it  remains  to  be  determined  whether  the  MR  also 
contributes to mounting an immune response to the toxin.  
It is interesting to note that, in our hands, ricin attachment and uptake into monocytes/macrophages 
occurs primarily via the RTB-mediated pathway. For example, treatment of THP-1 cells with mannan 
or a MR blocking antibody reduced ricin binding to cell surfaces by 20–50%. In contrast, binding was 
reduced by more than 80% with the addition of lactose. The addition of mannan did not reduce toxin 
binding beyond that observed with lactose alone. Based on these observations, we postulate that ricin 
uptake via the MR may occur in a two-step fashion. Specifically, we propose that ricin may first 
adhere to cell surfaces via RTB’s affinity for Gal/GalNac. Once bound to the cell surface, ricin may 
associate with the MR via mannose side chains on RTA and/or RTB. This model would explain our Toxins 2011, 3                                       
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observation that monoclonal antibodies that block RTB’s galactose recognition activity (but do not 
affect  accessibility  of  the  mannose  side  chains)  completely  neutralize  ricin  in  vitro  [38],  block 
attachment of ricin to primary macrophages ex vivo, and protect mice against a lethal ricin challenge 
(A. Yermakova and N. Mantis, in press).  
In  conclusion,  we  have  demonstrated  that  MR
−/−  mice  are  significantly  more  susceptible  to  
ricin-induced intoxication than age-matched, wild-type counterparts. These data are consistent with the 
MR contributing to ricin recognition in vivo, but indicate that the ricin’s fate following uptake via the 
MR is one of degradation and not intoxication. Thus, the fate of ricin following MR uptake may differ 
in vitro (or ex vivo) versus in vivo. Why this is the case is not immediately apparent, but may be due in 
part to influences by local environments in vivo that are not recapitulated in vitro. It should be stressed, 
however, that the actual fate of ricin in the MR
−/− mice following intraperitoneal injection was not 
determined in this study. Thus, while we propose that the susceptibility of the MR
−/− mice to ricin is 
due to the failure of macrophages to efficiently clear the toxin from circulation, there are other possible 
explanations. For example, we cannot exclude the possibility that soluble MR or other serum proteins 
contribute  to  the  scavenging  ricin  in  circulation  and/or  interstitial  fluids  (e.g.,  in  the  peritoneal  
cavity) [53]. Nor can we ignore the observation that MR
−/− mice have elevated serum levels of at least 
three proteins associated with inflammation and wound healing [35] that could possibility interfere 
directly or indirectly with ricin toxicity. Future studies will be aimed at defining the exact role for MR 
in the clearance of ricin in vivo and determining how this activity might be exploited in developing 
countermeasures against this toxin.  
Acknowledgments 
We  would  like  to  extend  our  thanks  to  the  laboratory  of  Michel  Nussenzweig  (Rockefeller 
University) for providing us with  MR knockout  mouse breeder pairs.  We gratefully  acknowledge 
Magdia De Jesus for assistance with the serum half-life studies. We also thank Anastasyia Yermakova 
for technical advice, and Renjie Song (Wadsworth Center’s Immunology Core) for help with flow 
cytometry. This work was supported by grant AI081053-1 from the National Institute of Allergy and 
Infectious Diseases (NIAID) to NJM. 
Conflict of Interest 
The authors declare no conflict of interest. 
References 
1.  Audi, J.; Belson, M.; Patel, M.; Schier J.; Osterloh J. Ricin poisoning: A comprehensive review.  
J. Am. Med. Assoc. 2005, 294, 2342–2351. 
2.  Olsnes, S. The history of ricin, abrin and related toxins. Toxicon 2004, 44, 361–370. 
3.  Sandvig, K.; van Deurs, B. Delivery into cells: Lessons learned from plant and bacterial toxins. 
Gene. Ther. 2005, 12, 865–872. 
4.  Franz, D.; Jaax, N. Ricin Toxin. In Textbook of Military Medicine; Zajtchuk, R.B., Ed.; Borden 
Institute: Washington, DC, USA, 1997; pp. 631–642. Toxins 2011, 3                                       
 
 
1142 
5.  Maman, M.; Yehezkelli, Y. Ricin: A Possible, Non-Infectious Biological Weapon. In Bioterrorism 
and Infectious Agents; Fong, S., Alibek, K., Eds.; Springer Science and Business Media: New 
York, NY, USA, 2005; pp. 205–216. 
6.  Hulse, C. Tests indicate poison in senate mail room of majority leader. N. Y. Times 2004, Sect. 12. 
7.  Schier, J.G.; Patel, M.M.; Belson, M.G.; Patel, A.; Schwartz, M.; Fitzpatrick, N.; Drociuk, D.; 
Deitchman, S.; Meyer, R.; Litovitz, T.; Watson, W.A.; Rubin, C.H.; Kiefer, M. Public health 
investigation after the discovery of ricin in a South Carolina postal facility. Am. J. Public Health 
2007, 97, S152–S157. 
8.  Summary of the NIAID Ricin Expert Panel Workshop; National Institutes of Health: Bethesda, 
MD, USA, 2004. 
9.  Endo, Y.; Mitsui, K.; Motizuki, M.; Tsurugi, K. The mechanism of action of ricin and related 
toxins on eukaryotic ribosomes. J. Biol. Chem. 1987, 262, 5908–5912. 
10.  Eiklid, K.; Olsnes, S.; Pihl, A. Entry of lethal doses of abrin, ricin and modeccin into the cytosol 
of HeLa cells. Exp. Cell Res. 1980, 126,321–326. 
11.  Baenziger,  J.U.;  Fiete,  D.  Structural  determinants  of  Ricinus  communis  agglutinin  and  toxin 
specificity for oligosaccharides. J. Biol. Chem. 1979, 254, 9795–9799. 
12.  Foxwell, B.M.; Donovan, T.A.; Thorpe, P.E.; Wilson, G. The removal of carbohydrates from ricin 
with endoglycosidases H, F and D and alpha-mannosidase. Biochim. Biophys. Acta 1985, 840, 
193–203. 
13.  Kimura, Y.; Hase, S.; Kobayashi, Y.; Kyogoku, Y.; Ikenaka, T.; Funatsu, G. Structures of sugar 
chains of ricin D. J. Biochem. (Tokyo) 1988, 103, 944–949. 
14.  Bradberry, S.M.; Dickers, K.J.; Rice, P.; Griffiths, G.D.; Vale, J.A. Ricin poisoning. Toxicol. Rev. 
2003, 22, 65–70. 
15.  Bingen, A.; Creppy, E.E.; Gut, J.P.; Dirheimer, G.; Kirn, A. The Kupffer cell is the first target in 
ricin-induced hepatitis. J. Submicrosc. Cytol. 1987, 19, 247–256. 
16.  Derenzini,  M.;  Bonetti,  E.;  Marionozzi,  V.;  Stirpe,  F.  Toxic  effects  of  ricin:  Studies  on  the 
pathogenesis of liver lesions. Virchows Arch. B 1976, 20, 15–28. 
17.  Fodstad, O.; Olsnes, S.; Pihl, A. Toxicity, distribution and elimination of the cancerostatic lectins 
abrin and ricin after parenteral injection into mice. Br. J. Cancer 1976, 34, 418–425. 
18.  Skilleter, D.N.; Foxwell, B.M. Selective uptake of ricin A-chain by hepatic non-parenchymal cells 
in vitro. Importance of mannose oligosaccharides in the toxin. FEBS Lett. 1986, 196, 344–348. 
19.  Thorpe,  P.E.;  Detre,  S.I.;  Foxwell,  B.M.;  Brown,  A.N.;  Skilleter,  D.N.;  Wilson,  G.;  
Forrester,  J.A.;  Stirpe,  F.  Modification  of  the  carbohydrate  in  ricin  with  metaperiodate-
cyanoborohydride mixtures. Effects on toxicity and in vivo distribution. Eur. J. Biochem. 1985, 
147, 197–206. 
20.  Zenilman, M.E.; Fiani, M.; Stahl, P.; Brunt, E.; Flye, M.W. Use of ricin A-chain to selectively 
deplete Kupffer cells. J. Surg. Res. 1988, 45, 82–89. 
21.  Brown, R.F.; White, D.E. Ultrastructure of rat lung following inhalation of ricin aerosol. Int. J. 
Exp. Path. 1997, 78, 267–276. 
22.  Gonzalez,  T.V.;  Farrant,  S.A.;  Mantis,  N.J.  Ricin  induces  IL-8  secretion  from  human 
monocyte/macrophages by activating the p38 MAP kinase pathway.  Mol. Immunol. 2006, 43, 
1920–1923. Toxins 2011, 3                                       
 
 
1143 
23.  Higuchi, S.; Tamura, T.; Oda, T. Cross-talk between the pathways leading to the induction of 
apoptosis  and  the  secretion  of  tumor  necrosis  factor-alpha  in  ricin-treated  RAW  264.7  cells.  
J. Biochem. (Tokyo) 2003, 134, 927–933. 
24.  Korcheva,  V.;  Wong,  J.;  Lindauer,  M.;  Jacoby,  D.B.;  Iordanov,  M.S.;  Magun,  B.  Role  of 
apoptotic signaling pathways in regulation of inflammatory responses to ricin in primary murine 
macrophages. Mol. Immunol. 2007, 44, 2761–2771. 
25.  Licastro,  F.;  Morini,  M.C.;  Bolognesi,  A.;  Stirpe.  F.  Ricin  induces  the  production  of  tumour 
necrosis  factor-alpha  and  interleukin-1  beta  by  human  peripheral-blood  mononuclear  cells. 
Biochem. J. 1993, 294, 517–520. 
26.  Frankel,  A.E.;  Fu,  T.;  Burbage,  C.;  Tagge,  E.;  Harris,  B.;  Vesely,  J.;  Willingham,  M.C.  
Lectin-deficient ricin toxin intoxicates cells bearing the D-mannose receptor. Carbohydr. Res. 
1997, 300, 251–258. 
27.  Simmons, B.M.; Stahl, P.D.; Russell, J.H. Mannose receptor-mediated uptake of ricin toxin and 
ricin A chain by macrophages. Multiple intracellular pathways for a chain translocation. J. Biol. 
Chem. 1986, 261, 7912–7920. 
28.  Spooner,  R.A.;  Lord,  J.M.  How  ricin  and  shiga  toxin  reach  the  cytosol  of  target  cells: 
Retrotranslocation  from  the  endoplasmic  reticulum.  Curr.  Top.  Microbiol.  Immunol.  2011,  in 
press.  
29.  Van Deurs, B.; Sandvig, K.; Petersen, O.W.; Olsnes, S.; Simons, K.; Griffiths, G. Estimation of 
the amount of internalized ricin that reaches the trans-Golgi network. J. Cell Biol. 1988, 106, 
253–267. 
30.  Sandvig, K.; Olsnes, S.; Pihl, A. Kinetics of binding of the toxic lectins abrin and ricin to surface 
receptors of human cells. J. Biol. Chem. 1976, 251, 3977–3984. 
31.  Magnusson, S.; Berg, T. Endocytosis of ricin by rat liver cells in vivo and in vitro is mainly 
mediated by mannose receptors on sinusoidal endothelial cells. Biochem. J. 1993, 291, 749–755. 
32.  East, L.; Isacke, C.M. The mannose receptor family. Biochim. Biophys. Acta 2002, 1572, 364–386. 
33.  Taylor, P.R.; Gordon, S.; Martinez-Pomares, L. The mannose receptor: Linking homeostasis and 
immunity through sugar recognition. Trends Immunol. 2005, 26, 104–110. 
34.  Kerrigan, A.M.; Brown, G.D. C-type lectins and phagocytosis. Immunobiology 2009, 214, 562–575. 
35.  Lee,  S.J.;  Evers,  S.;  Roeder,  D.;  Parlow,  A.F.;  Risteli,  J.;  Risteli,  L.;  Lee,  Y.C.;  Feizi,  T.;  
Langen, H.; Nussenzweig, M.C. Mannose receptor-mediated regulation  of serum glycoprotein 
homeostasis. Science 2002, 295, 1898–1901. 
36.  Auwerx,  J.  The  human  leukemia  cell  line,  THP-1:  A  multifacetted  model  for  the  study  of 
monocyte-macrophage differentiation. Experientia 1991, 47, 22–31. 
37.  Van  Engeland,  M.;  Ramaekers,  F.C.;  Schutte,  B.;  Reutelingsperger,  C.P.  A  novel  assay  to 
measure  loss  of  plasma  membrane  asymmetry  during  apoptosis  of  adherent  cells  in  culture. 
Cytometry 1996, 24, 131–139. 
38.  McGuinness,  C.R.;  Mantis,  N.J.  Characterization  of  a  novel  high-affinity  monoclonal 
immunoglobulin G antibody against the ricin B subunit. Infect. Immun. 2006, 74, 3463–3470. 
39.  Baumann, J.; Park, C.G.; Mantis, N.J. Recognition of secretory IgA by DC-SIGN: Implications 
for immune surveillance in the intestine. Immunol. Lett. 2010, 131, 59–66. Toxins 2011, 3                                       
 
 
1144 
40.  Diaz-Silvestre,  H.;  Espinosa-Cueto,  P.;  Sanchez-Gonzalez,  A.;  Esparza-Ceron,  M.A.;  
Pereira-Suarez,  A.L.;  Bernal-Fernandez,  G.;  Espitia,  C.;  Mancilla,  R.  The  19-kDa  antigen  of 
Mycobacterium  tuberculosis  is  a  major  adhesin  that  binds  the  mannose  receptor  of  THP-1 
monocytic cells and promotes phagocytosis of mycobacteria. Microb. Pathog. 2005, 39, 97–107. 
41.  Puig-Kroger,  A.;  Serrano-Gomez,  D.;  Caparros,  E.;  Dominguez-Soto,  A.;  Relloso,  M.; 
Colmenares, M.; Martí nez-Muñ oz, L.; Longo, N.; Sá nchez-Sá nchez, N.; Rincon, M.; Rivas, L.; 
Sá nchez-Mateos,  P.;  Ferná ndez-Ruiz,  E.;  Corbí ,  A.L.  Regulated  expression  of  the  pathogen 
receptor dendritic cell-specific intercellular adhesion molecule 3 (ICAM-3)-grabbing nonintegrin 
in  THP-1  human  leukemic  cells,  monocytes,  and  macrophages.  J.  Biol.  Chem.  2004,  279,  
25680–25688. 
42.  Sandvig, K.; Olsnes, S. Effect of temperature on the uptake, excretion and degradation of abrin 
and ricin by HeLa cells. Exp. Cell Res. 1979, 121, 15–25. 
43.  Neal, L.M.; O’Hara, J.; Brey, R.N., 3rd.; Mantis, N.J. A monoclonal immunoglobulin G antibody 
directed against an immunodominant linear epitope on the ricin A chain confers systemic and 
mucosal immunity to ricin. Infect. Immun. 2010, 78, 552–561. 
44.  Pincus, S.H.; Eng, L.; Cooke, C.L.; Maddaloni, M. Identification of hypoglycemia in mice as a 
surrogate marker of ricin toxicosis. Comp. Med. 2002, 52, 530–533. 
45.  Yoder, J.M.; Aslam, R.U.; Mantis, N.J. Evidence for widespread epithelial damage and coincident 
production of monocyte chemotactic protein 1 in a murine model of intestinal ricin intoxication. 
Infect. Immun. 2007, 75, 1745–1750. 
46.  Kang,  B.K.;  Schlesinger,  L.S.  Characterization  of  mannose  receptor-dependent  phagocytosis 
mediated by Mycobacterium tuberculosis lipoarabinomannan. Infect. Immun. 1998, 66, 2769–2777. 
47.  Zamze,  S.;  Martinez-Pomares,  L.;  Jones,  H.;  Taylor,  P.R.;  Stillion,  R.J.;  Gordon,  S.;  
Wong, S.Y.C. Recognition of bacterial capsular polysaccharides and lipopolysaccharides by the 
macrophage mannose receptor. J. Biol. Chem. 2002, 277, 41613–41623. 
48.  Schulert,  G.S.;  Allen,  L.A.  Differential  infection  of  mononuclear  phagocytes  by  Francisella 
tularensis: Role of the macrophage mannose receptor. J. Leukoc. Biol. 2006, 80, 563–571. 
49.  Ezekowitz,  R.A.;  Williams,  D.J.;  Koziel,  H.;  Armstrong,  M.Y.;  Warner,  A.;  Richards,  F.F.;  
Rose,  R.M.  Uptake  of  Pneumocystis  carinii  mediated  by  the  macrophage  mannose  receptor. 
Nature 1991, 351, 155–158. 
50.  Lee, S.J.; Zheng, N.Y.; Clavijo, M.; Nussenzweig, M.C. Normal host defense during systemic 
candidiasis in mannose receptor-deficient mice. Infect. Immun. 2003, 71, 437–445. 
51.  Dan, J.M.; Kelly, R.M.; Lee, C.K.; Levitz, S.M. Role of the mannose receptor in a murine model 
of Cryptococcus neoformans infection. Infect. Immun. 2008, 76, 2362–2367. 
52.  Burgdorf, S.; Kautz, A.; Bohnert, V.; Knolle, P.A.; Kurts, C. Distinct pathways of antigen uptake 
and intracellular routing in CD4 and CD8 T cell activation. Science 2007, 316, 612–616. 
   Toxins 2011, 3                                       
 
 
1145 
53.  Martinez-Pomares,  L.;  Mahoney,  J.A.;  Kaposzta,  R.;  Linehan,  S.A.;  Stahl,  P.D.;  Gordon,  S.  
A functional soluble form of the murine mannose receptor is produced by macrophages in vitro 
and is present in mouse serum. J. Biol. Chem. 1998, 273, 23376–23380. 
© 2011 by the authors; licensee MDPI,  Basel,  Switzerland. This  article is  an open  access  article 
distributed  under  the  terms  and  conditions  of  the  Creative  Commons  Attribution  license 
(http://creativecommons.org/licenses/by/3.0/). 